2nd Quarter - Report

W STRATEGIES, LLC for ABBOTT LABORATORIES

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Taxation/Internal Revenue Code TAX

H.R.4617: Protect Medical Innovation Act.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4617 (115th)

Medicare/Medicaid MMM

Education about the importance of proper reimbursement for home monitoring services for anticoagulation management. Education about the regulation of continuous glucose monitor technologies including CMS regulation of CGM.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Development of legislation regulated to regulation of LDT's, including a discussion draft of Diagnostic Accuracy and Improvement Act. Reauthorization of PAHPA (Pandemic All Hazards Preparedness Act). H.R.6: Support for Patients and Communities Act as it relates to provisions designed to promote the importance of non-pharmacological pain treatment options, including medical devices.

LobbyistCovered position, as disclosed
DARREN WILLCOX —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 6 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.